Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma

被引：0
作者：
Guo, Ting [1 ]
Li, Bin [1 ]
Gu, Chao [1 ]
机构：
[1] Fudan Univ, Dept Obstet & Gynaecol, Gynaecol Hosp, Shanghai 200011, Peoples R China
来源：
JOURNAL OF BUON | 2013年 / 18卷 / 02期
关键词：
endometrial carcinoma; estrogen receptor; human phosphatidylethanolamine-binding protein 4; progesterone receptor; PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; ALPHA-INDUCED APOPTOSIS; CANCER-CELLS; ER-ALPHA; BREAST-CANCER; BETA; ASSOCIATION; ACTIVATION; THERAPY; PR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose: To investigate the expression of human phosphatidylethanolamine-binding protein 4 (hPEBP4) in endometrial carcinoma and its relation with progesterone receptor (PR) and estrogen receptor (ER). Methods: Forty-five samples of endometrioid endometrial carcinoma (EEC), 12 samples of atypical endometrial hyperplasia, and 30 samples of normal endometrium were examined. Samples were studied by immunohistochemistry for PR, ER and hPEBP4 expression. Expressions were statistically quantified and analyzed. Results: Expressions of PR and ER were significantly higher in normal endometrium than in cancer. Expression of hPEBP4 was significantly lower in normal endometrium. The expression of hPEBP4 was significantly higher in advanced-stage endometrial cancer, whilst higher but insignificant trend was noticed in higher grade carcinoma. Statistically insignificant trend of negative ER and PR expression with higher grade or stage was noticed. The expression of hPEBP4 was negatively correlated to ER and PR in EEC. Conclusion: The expression pattern of hPEBP4 indicated that hPEBP4 interacted with ER and PR in EEC and could thus become a possible target for the development of novel treatment against this malignancy.
引用
收藏
页码：465 / 470
页数：6
相关论文
共 27 条
[1]   Endometrial cancer [J].
Amant, F ;
Moerman, P ;
Neven, P ;
Timmerman, D ;
Van Limbergen, E ;
Vergote, I .
LANCET, 2005, 366 (9484) :491-505
[2]   Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein [J].
Corbit, KC ;
Trakul, N ;
Eves, EM ;
Diaz, B ;
Marshall, M ;
Rosner, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :13061-13068
[3]   Hormone therapy in advanced and recurrent endometrial cancer: a systematic review [J].
Decruze, S. B. ;
Green, J. A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (05) :964-978
[4]   Clinical implications of the expression of estrogen receptor-α and -β in primary and metastatic lesions of uterine endometrial cancers [J].
Fujimoto, J ;
Sakaguchi, H ;
Aoki, I ;
Toyoki, H ;
Tamaya, T .
ONCOLOGY, 2002, 62 (03) :269-277
[5]   Progesterone receptors: Various forms and functions in reproductive tissues [J].
Gadkar-Sable, S ;
Shah, C ;
Rosario, G ;
Sachdeva, G ;
Puri, C .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :2118-2130
[6]   MONOCLONAL-ANTIBODIES TO ESTROPHILIN - PROBES FOR THE STUDY OF ESTROGEN-RECEPTORS [J].
GREENE, GL ;
FITCH, FW ;
JENSEN, EV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (01) :157-161
[7]   Reflections on the discovery and significance of estrogen receptor β [J].
Koehler, KF ;
Helguero, LA ;
Haldosén, LA ;
Warner, M ;
Gustafsson, JÅ .
ENDOCRINE REVIEWS, 2005, 26 (03) :465-478
[8]  
Li P, 2006, INT J MOL MED, V18, P505
[9]   Human Phosphatidylethanolamine-binding Protein 4 Promotes Transactivation of Estrogen Receptor α (ERα) in Human Cancer Cells by Inhibiting Proteasome-dependent ERα Degradation via Association with Src (Publication with Expression of Concern. See vol. 295, pg. 8883, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021) [J].
Liu, Haibo ;
Qiu, Jianming ;
Li, Nan ;
Chen, Taoyong ;
Cao, Xuetao .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (29) :21934-21942
[10]   Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer [J].
Liu, Hongyi ;
Kong, Qingling ;
Li, Bing ;
He, Yuanxiang ;
Li, Peng ;
Jia, Baoqing .
TUMOR BIOLOGY, 2012, 33 (01) :267-273
123